Accendra Health Inc (ACH) stock
Close on Nov 11, 2026Market cap $11.17MP/E –Yield –
Accendra Health Inc saw revenue fall 7.1% to $2.55B over the twelve months to Sep 30, 2026. Free cash flow was -$199.12M. At the latest close the market valued the company at $11.17M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $11.17M
- P/E ratio
- –
- Price to sales
- 0.00
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -1783.16%
Fundamentals
- Revenue
- $2.55B
- Net income
- -$171.56M
- EPS, diluted
- -$2.23
- Free cash flow
- -$199.12M
- Book value per share
- -$7.39
- Diluted shares
- 77M
Trading
- Next earnings
- Feb 18, 2027 (estimated, after the close)
- Previous close
- $0.15
- Open
- $0.15
- Day's range
- $0.13 – $0.15
- Volume
- 2,953,258
- Average volume (20 days)
- 4,317,633
- Index membership
- Russell 2000, Russell 3000
- Beta (5 years)
- 1.42
- 52-week range
- $0.13 – $4.69
- RSI (14 days)
- 23.6
- Volatility (1 year)
- 111.1%
- Relative volume
- 1.44×
- WACC
- 6.0%
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | ACH | S&P 500 | Difference | ACH per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -66.1% | -2.4% | −63.7 pts | ||
| 3 months | -88.5% | -1.2% | −87.3 pts | ||
| Year to date | -94.8% | +12.3% | −107.1 pts | ||
| 1 year | -94.9% | +12.4% | −107.4 pts | ||
| 3 years | -99.2% | +78.8% | −178.0 pts | -79.6% | +21.4% |
| 5 years | -99.7% | +75.2% | −174.8 pts | -67.8% | +11.9% |
| 10 years | -99.5% | +311.1% | −410.6 pts | -41.2% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Accendra Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Update
- Update
- Update
About Accendra Health
Wholesale-Medical, Dental & Hospital Equipment & Supplies
Accendra Health, Inc. provides medical supplies, technology, and home healthcare equipment across the United States. Its offerings focus on home respiratory therapy, obstructive sleep apnea treatment, diabetes care, wound care, and ostomy supplies. The company also delivers clinical support and patient management services designed to facilitate medical treatment outside acute care facilities. It operates primarily under brands such as Apria and Byram Healthcare, distributing products directly to individual patients as well as home health agencies. Reimbursement and payment arrangements involve commercial health insurers, managed care plans, state Medicaid programs, federal Medicare coverage, and direct out-of-pocket patient payments.
Company profile, executives and historyAccendra Health stock: common questions
What is Accendra Health's stock price?
ACH closed at $0.15 on Nov 11, 2026, down 4.28% on the day. Over the past 52 weeks it traded between $0.13 and $4.69.
What is Accendra Health's market cap?
Accendra Health was worth $11.17M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is ACH's P/E ratio?
Accendra Health lost money over the twelve months to Sep 30, 2026 (diluted EPS -$2.23), so it has no meaningful P/E ratio.
How much revenue does Accendra Health make?
Accendra Health reported revenue of $2.55B for the twelve months to Sep 30, 2026, down 7.1% from a year earlier.
Does Accendra Health pay a dividend?
No. Accendra Health has not paid a cash dividend over the last twelve months.
When does Accendra Health report earnings next?
Accendra Health is expected to report Q4 FY2026 results on Feb 18, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has ACH stock performed over the past year?
Including dividends, ACH returned -94.9% over the past year, against +12.4% for the S&P 500.
How many ACH shares are sold short?
10M shares were sold short at the latest FINRA report, 16.77% of the float, or 4.0 days of average trading volume.
Who are Accendra Health's competitors?
Companies most similar to Accendra Health by business, industry and size include HSIC, PLUS, AHCO, CNXN, SCSC.
See a number that looks wrong?